Document is current
Any future updates will be listed below
-
Authors
Yang, Shih-Hung
Kuo, Sung-Hsin
Lee, Jen-Chieh
Chen, Bang-Bin
Shan, Yan-Shen
Tien, Yu-Wen
Chiu, Sz-Chi
Cheng, Ann-Lii
Yeh, Kun-Huei
-
Funding
Funding for this research was provided by:
National Taiwan University Hospital (112-S0011)
- License Information
-
More Information
Article History
Received: 4 July 2024
Accepted: 28 August 2024
First Online: 9 September 2024
Declarations
:
: Ono Pharmaceutical Co., Ltd supported nivolumab for an investigator-initiated clinical trial (principal investigator: Yang SH) in pancreatic cancer at National Taiwan University Hospital.
: This retrospective study was approved by the Research Ethics Committee (REC) of National Taiwan University Hospital (REC No. 202206104RINC).
: Formal consent was waived for this type of study.
